FireTofu
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business

Business · en

Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business

Nikkei Asia · Oct 5, 2026, 4:26 PM UTC

OSAKA/TOKYO -- Japanese drugmaker Shionogi will acquire U.S.-based biopharma company IntraBio for $2 billion, aiming to make treatments for rare disea